Search for: "Sanofi"
Results 241 - 260
of 1,195
Sorted by Relevance
|
Sort by Date
21 Apr 2021, 4:15 am
Translate BIO also appears to have one infectious disease candidate in the “IND-enabling” Phase (with Sanofi), and three lung candidates, one liver candidate, and two infectious disease candidates (with Sanofi) in the discovery phase. [read post]
15 Dec 2023, 12:48 pm
This week in Other Barks & Bites: a group of authors filed a trimmed-down lawsuit against Meta accusing the company of infringing copyright to train generative AI models; the FTC authorizes a lawsuit against Sanofi accusing a potential acquisition of being a move to monopolize Pompe disease drug development; and Chinese courts publish rulings to combat malicious trademarks. [read post]
15 Dec 2023, 12:48 pm
This week in Other Barks & Bites: a group of authors filed a trimmed-down lawsuit against Meta accusing the company of infringing copyright to train generative AI models; the FTC authorizes a lawsuit against Sanofi accusing a potential acquisition of being a move to monopolize Pompe disease drug development; and Chinese courts publish rulings to combat malicious trademarks. [read post]
7 Jan 2017, 4:24 pm
The whistleblower in the Sanofi Aventis case assists the government in stopping fraud by Sanofi Aventis, by exposing the company’s illegal marketing tactics and illegal bribes to physicians to push taxotere. [read post]
7 Jan 2017, 4:24 pm
The whistleblower in the Sanofi Aventis case assists the government in stopping fraud by Sanofi Aventis, by exposing the company’s illegal marketing tactics and illegal bribes to physicians to push taxotere. [read post]
7 Nov 2008, 8:35 am
Sanofi-Synthelabo Canada Inc. [read post]
14 Nov 2008, 2:25 am
It is produced and marketed by Procter & Gamble and Sanofi-Aventis. [read post]
17 Feb 2011, 8:13 am
The Genzyme-Sanofi transaction is being structured as a tender offer with a back end short form merger (merger agreement). [read post]
11 Feb 2011, 3:21 pm
Plus: updates on Genzyme and Sanofi-Aventis and more deal news. [read post]
21 Feb 2011, 2:11 am
For those of you looking for an example of a publicly traded contingent value right agreement, you can download the Genzyme/Sanofi CVR here. [read post]
2 Aug 2010, 2:57 am
With activist directors driving up the price, Sanofi-Aventis could find itself shelling out at least $80 a share, or $21.3 billion, to acquire drugmaker Genzyme, Bloomberg News reported. [read post]
11 Oct 2010, 5:48 am
Today's Lex column in the FT.com has a quickie review of some of the potential defenses available to Genzyme in its fight to stave of Sanofi - the pacman defense*, the macaroni defense**, the poison pill, scorched earth tactics, and... [read post]
22 Nov 2010, 5:42 am
Gina Chon and Preeta Das at the WSJ have an article this morning suggesting that Genzyme might be open to a deal with Sanofi if it's given certain back-end protections for its shareholders. [read post]
7 May 2012, 10:42 am
A former research chemist was sentenced to a year and a half in prison Monday after she admitted last year to stealing trade secrets from Sanofi-Aventis SA, the pharmaceutical company. [read post]
16 Feb 2011, 2:43 am
The Sanofi-Genzyme deal was announced this morning: $74/share cash plus a tradeable CVR: Terms of the CVR agreement call for additional cash payments under certain circumstances. [read post]
9 Aug 2018, 5:16 pm
Sanofi, Aventisub LLC, SCT Docket No. 18-127 (Petition filed July 23, 2018) (Cert Petition). [read post]
9 Jan 2008, 8:42 pm
28 Sep 2009, 9:05 pm
Class Action Complaint Alleging Securities Fraud Violations Arising from Disclosures Concerning Drug under Development Failed to State Claims under Section 10(b) of the Securities Exchange Act of 1934 or Rule 10b-5 New York Federal Court Holds Plaintiffs filed a putative class action against French pharmaceutical company Sanofi-Aventis and certain individual defendants alleging violations of the Securities Exchange Act of 1934; specifically, the class action complaint alleged that… [read post]
Three Strikes, You’re Out!? Apotex’s Latest Attempt to Invalidate the PLAVIX® Patent Denied by USPTO
9 Jul 2010, 3:00 am
Court of Appeals for the Federal Circuit (Sanofi-Synthelabo v. [read post]
6 Aug 2020, 7:01 am
Department of Justice Investigation Following the worldwide recalls and ban by the United States Food and Drug Administration (FDA) of antacid medicine Zantac, the Department of Justice announced it is investigating GlaxoSmithKline (GSK) and Sanofi for potential violations of the False Claims Act. [read post]
